Indeed, pharmacological blockade of peripheral cannabinoid subtype-1 receptors (CB1Rs) reduces food intake and improves metabolic dysfunction associated with obesity in rodents similarly to brain-penetrant CB1R antagonists [21,23,24,27,28,29,30,37]. This evidence concerns the gene CNR1 and obesity disorder.